期刊文献+

1例老年心肺疾病合并慢性肾功能不全患者的药学监护 被引量:2

Pharmaceutical Care for the Aged with Heart-lung Diseases Complicating with Chronic Renal Insufficiency
原文传递
导出
摘要 目的:探讨临床药师针对老年心肺疾病合并慢性肾功能不全患者的药学监护方法。方法:临床药师对1例老年心肺疾病合并慢性肾功能不全患者的抗菌药物、强心苷类、中药注射剂治疗进行药学监护。结果与结论:临床药师通过实践典型病例的药学监护,协同医师制订个体化给药方案,确保治疗药物的安全性和有效性;强调必须根据药敏试验选择抗菌药物,根据肌酐清除率调整抗菌药物剂量。 OBJECTIVE: To explore clinical pharmacists participating in pharmaceutical care for the aged with heart-lung diseases complicating with chronic renal insufficiency. METHODS: 1 case of heart-lung diseases complicating with chronic renal insufficiency was analyzed in term of antibacterials, cardiac glycoside and TCM injection. RESULTS&CONCLUSION: Clinical pharmacists develop pharmaceutical care for typical cases and help physicians to design individualized dosage regimen and improve the safety and effectiveness of medical treatments. It especially emphasizes that antibacterials selection should be based on susceptibility test and the dosage of antibacterials should be adjusted according to creatinine clearance rate.
出处 《中国药房》 CAS CSCD 北大核心 2011年第42期4028-4030,共3页 China Pharmacy
关键词 心肺疾病 慢性肾功能不全 临床药师 抗菌药物 强心苷类 中药注射剂 药学监护 Heart-lung disease Chronic renal insufficiency Clinical pharmacists Antibacterials Cardiac glycoside TCM injec- tion Pharmaceutical care
  • 相关文献

参考文献11

二级参考文献77

共引文献238

同被引文献25

  • 1α酮酸制剂在肾内科应用专家协作组.慢性肾脏病蛋白营养治疗共识[J].中华肾脏病杂志,2005,21(7):421-424. 被引量:137
  • 2谌贻璞.用促红细胞生成素治疗肾性贫血必须合理补铁[J].肾脏病与透析肾移植杂志,2006,15(4):345-346. 被引量:37
  • 3陈香美,孙雪峰,蔡广研.重组人促红细胞生成素在肾性贫血中合理应用的专家共识[J].中国血液净化,2007,6(8):440-443. 被引量:112
  • 4National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and strati- fication[ J. Am J Kidney Dis, 2002, 39 (Suppl 2) : S1 -S246.
  • 5JOEL DK. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure[ JJ. Ant J Kidney Dis, 2001, 37(Suppl 2) S66 - S70.
  • 6National Kidney Foundation. K/DOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kid- zey disease[J]. Am J Kidney Dis,2006,47(Suppl 3) : Sll - S145.
  • 7EDDINGTON H, HOEFIELD R, SINHA S, et al. Serum phos- phate and mortality in patients with chronic kidney disease [ J]. Clin ] Am Soc Nephrol, 2010,5(12) :2251 -2257.
  • 8EWENCE AE, BOOTMAN M, RODERICK HL, et al. Calcium phosphate crystals induce cell death in human vascular smooth muscle cells: a potential mechanism in atherosclerotic plaque de- stabilization[ J. Circ Res, 2008, 103 ( 5 ) : e28 - e34.
  • 9National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease J ]. Ant J Kidney Dis, 2003, 42( Suppl 3 ) :S1 - $201.
  • 10江警予,王奕,仇丽茹,周建华.美洛西林钠/舒巴坦钠致急性肾衰竭3例[J].中国医院药学杂志,2008,28(13):1140-1142. 被引量:11

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部